OMDA
Omada Health NASDAQ Listed Jun 6, 2025$23.67
After hrs
$24.14
+1.99%
Mkt Cap $1.4B
52w Low $10.28
80.5% of range
52w High $26.91
50d MA $19.93
200d MA $17.04
P/E (TTM)
269.8x
EV/EBITDA
78.2x
P/B
6.0x
Debt/Equity
0.0x
ROE
-5.6%
P/FCF
81.7x
RSI (14)
21.50
ATR (14)
$1.06
Beta
1.33
50d MA
$19.93
200d MA
$17.04
Avg Volume
1.4M
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
500 Sansome Street · San Francisco, CA 94111 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AMC | 0.06 | 0.15 | +141.2% | — | — | — | — | — | — | — | — |
| May 7, 2026 | AMC | -0.03 | 0.01 | +133.3% | 16.40 | +0.5% | -9.6% | -0.9% | +1.5% | +7.6% | +3.4% | — |
| Mar 5, 2026 | AMC | 0.03 | 0.13 | +333.3% | 13.60 | +0.1% | +3.3% | +2.4% | -1.0% | -3.6% | +2.0% | — |
| Nov 6, 2025 | AMC | -0.10 | -0.06 | +40.0% | 21.87 | +4.0% | -7.1% | +1.7% | +0.8% | +3.1% | -3.2% | — |
| Aug 7, 2025 | AMC | -0.10 | -0.09 | +10.0% | 19.46 | +2.8% | -2.3% | +0.2% | +1.2% | +4.1% | +1.6% | — |
| May 9, 2025 | AMC | -0.12 | -0.13 | -9.9% | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 | BTIG Research | Initiates | Buy | $30 | $23.67 | $23.84 | +0.7% | +0.1% | +0.8% | -3.8% | -5.0% | -2.9% |
| Apr 9 | Goldman Sachs | Maintains | Buy → Buy | — | $12.53 | $12.55 | +0.2% | -4.4% | -4.8% | +6.2% | +2.8% | +5.3% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $12.40 | $13.00 | +4.8% | +1.0% | -4.4% | -4.8% | +6.2% | +2.8% |
| Mar 12 | JP Morgan | Maintains | Overweight → Overweight | — | $13.74 | $13.70 | -0.3% | +2.0% | +3.6% | +1.9% | -1.2% | -3.5% |
| Mar 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $13.60 | $13.61 | +0.1% | +3.3% | +2.4% | -1.0% | -3.6% | +2.0% |
| Mar 6 | Barclays | Maintains | Overweight → Overweight | — | $13.60 | $13.61 | +0.1% | +3.3% | +2.4% | -1.0% | -3.6% | +2.0% |
| Mar 6 | BMO Capital | Maintains | Outperform → Outperform | — | $13.60 | $13.61 | +0.1% | +3.3% | +2.4% | -1.0% | -3.6% | +2.0% |
| Mar 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $13.60 | $13.61 | +0.1% | +3.3% | +2.4% | -1.0% | -3.6% | +2.0% |
| Mar 3 | Barclays | Maintains | Overweight → Overweight | — | $12.90 | $12.61 | -2.2% | +0.8% | +4.0% | +0.6% | +3.3% | +2.4% |
| Jan 22 | Needham | Maintains | Buy → Buy | — | $15.63 | $15.76 | +0.8% | +2.8% | +2.9% | -1.0% | -0.4% | -5.4% |
| Jan 5 | Barclays | Maintains | Overweight → Overweight | — | $14.90 | $14.84 | -0.4% | +0.7% | +6.9% | +3.3% | -0.8% | -6.3% |
| Nov 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $21.87 | $22.75 | +4.0% | -7.1% | +1.7% | +0.8% | +3.1% | -3.2% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $21.87 | $22.75 | +4.0% | -7.1% | +1.7% | +0.8% | +3.1% | -3.2% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $21.87 | $22.75 | +4.0% | -7.1% | +1.7% | +0.8% | +3.1% | -3.2% |
| Oct 22 | Barclays | Maintains | Overweight → Overweight | — | $25.12 | $25.51 | +1.6% | -0.8% | +3.1% | +0.7% | +2.1% | +1.4% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $19.46 | $20.00 | +2.8% | -2.3% | +0.2% | +1.2% | +4.1% | +1.6% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $19.46 | $20.00 | +2.8% | -2.3% | +0.2% | +1.2% | +4.1% | +1.6% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $19.46 | $20.00 | +2.8% | -2.3% | +0.2% | +1.2% | +4.1% | +1.6% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $17.48 | $17.40 | -0.5% | -3.6% | +6.4% | -1.4% | -0.7% | +2.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 12,944 | $20.40 | $264K | 411,861 | +2.25% | — |
| Jul 13, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 600 | $24.01 | $14K | 187,209 | -0.25% | -5.00% |
| Jul 13, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 5,200 | $24.00 | $125K | 187,809 | -0.25% | -5.00% |
| Jul 13, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 1,041 | $24.00 | $25K | 15,441 | -0.25% | -5.00% |
| Jul 7, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 12,337 | $23.09 | $285K | 187,209 | +2.48% | +1.24% |
| Jul 1, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 23,263 | $22.76 | $530K | 187,209 | +2.48% | +1.24% |
| Jul 1, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 12,942 | $22.67 | $293K | 411,861 | +0.66% | +0.94% |
| Jul 1, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 12,944 | $22.70 | $294K | 411,861 | +0.66% | +0.94% |
| Jul 1, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 637 | $23.00 | $15K | 15,441 | +2.05% | -1.15% |
| Jun 30, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 300 | $22.00 | $7K | 115,409 | +2.05% | -1.15% |
| Jun 30, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 405 | $22.00 | $9K | 15,441 | +2.05% | -1.15% |
| Jun 29, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 17,950 | $21.07 | $378K | 187,209 | +2.48% | +1.24% |
| Jun 29, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,083 | $21.00 | $44K | 15,441 | +2.48% | +1.24% |
| Jun 29, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 17,950 | $21.07 | $378K | 115,409 | +3.05% | -0.09% |
| Jun 29, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,083 | $21.00 | $44K | 858 | +3.05% | -0.09% |
| Jun 26, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 33,000 | $19.89 | $656K | 187,209 | +2.48% | +1.24% |
| Jun 26, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,084 | $20.00 | $42K | 15,441 | +2.48% | +1.24% |
| Jun 26, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 4,314 | $20.90 | $90K | 411,861 | +2.48% | +1.24% |
| Jun 26, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 9,844 | $19.61 | $193K | 411,861 | +2.48% | +1.24% |
| Jun 26, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 33,000 | $19.89 | $656K | 133,359 | +3.05% | -0.09% |
| Jun 26, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,084 | $20.00 | $42K | 2,941 | +3.05% | -0.09% |
| Jun 25, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 300 | $19.00 | $6K | 187,209 | +2.48% | +1.24% |
| Jun 25, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 300 | $19.00 | $6K | 411,861 | +2.48% | +1.24% |
| Jun 24, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 2,600 | $19.02 | $49K | 187,209 | +2.48% | +1.24% |
| Jun 24, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,083 | $19.01 | $40K | 15,441 | +2.48% | +1.24% |
| Jun 24, 2026 | Duffy Sean P. | Chief Executive Officer | Sell | 2,800 | $19.01 | $53K | 411,861 | +2.48% | +1.24% |
| Jun 22, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 17,950 | $18.13 | $325K | 187,209 | +2.48% | +1.24% |
| Jun 22, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,083 | $18.00 | $37K | 15,441 | +2.48% | +1.24% |
| Jun 22, 2026 | Gracey Craig | Chief Accounting Officer | Sell | 2,083 | $18.00 | $37K | 7,108 | +1.61% | +3.05% |
| Jun 22, 2026 | Cook Steven L. | Chief Financial Officer | Sell | 17,950 | $18.13 | $325K | 169,259 | +1.61% | +3.05% |
8-K
Omada Health -- 8-K Filing
I cannot provide a meaningful investor analysis from this filing summary, as it contains only procedural voting information without disclosing a material corporate event or transaction.
Jun 16
8-K · 2.02
!! High
Omada Health -- 8-K 2.02: Earnings Results
Omada Health reported Q1 2026 financial results, providing investors with updated operational performance and financial condition metrics for the quarter ended March 31.
May 7
8-K
Omada Health, Inc. -- 8-K Filing
Omada Health demonstrated strong operational momentum with 58% quarterly revenue growth, 55% annual member expansion, and achievement of positive net income in Q4, signaling progress toward sustained profitability.
Mar 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Divisadero Street Capital Management, Lp | 5,887,715 | $74M | Added | Mar 2026 |
| 2 | Revelation Capital Management, Llc | 5,208,034 | $65M | — | Mar 2026 |
| 3 | Fmr Llc | 3,288,380 | $41M | Reduced | Mar 2026 |
| 4 | Civilization Ventures Management, Llc | 1,501,890 | $24M | New | Dec 2025 |
| 5 | Vanguard Capital Management Llc | 1,808,984 | $23M | New | Mar 2026 |
| 6 | Millennium Management | 1,103,995 | $14M | Reduced | Mar 2026 |
| 7 | Morgan Stanley | 824,212 | $13M | Added | Dec 2025 |
| 8 | Point72 Asset Management | 906,207 | $11M | Added | Mar 2026 |
| 9 | Bienville Capital Management, Llc | 897,765 | $11M | Added | Mar 2026 |
| 10 | Sg Americas Securities, Llc | 827,447 | $10M | New | Mar 2026 |
| 11 | Archon Capital Management Llc | 725,120 | $9M | Added | Mar 2026 |
| 12 | Renaissance Technologies Llc | 391,069 | $5M | Added | Mar 2026 |
| 13 | Tudor Investment Corp | 378,438 | $5M | New | Mar 2026 |
| 14 | Jpmorgan Chase & Co | 346,016 | $4M | Reduced | Mar 2026 |
| 15 | Aqr Capital Management Llc | 305,661 | $4M | New | Mar 2026 |
| 16 | Vanguard Portfolio Management Llc | 266,046 | $3M | New | Mar 2026 |
| 17 | Rtw Investments, Lp | 200,000 | $3M | — | Mar 2026 |
| 18 | Jane Street Group, Llc | 157,361 | $2M | New | Dec 2025 |
| 19 | Northern Trust Corp | 194,974 | $2M | Added | Mar 2026 |
| 20 | Bnp Paribas Financial Markets | 174,457 | $2M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.41B
Enterprise Value
$919.7M
P/E (TTM)
269.83x
Forward P/E
—
PEG Ratio
0.97x
P/B
6.02x
P/S
4.46x
P/FCF
81.69x
EV/EBITDA
78.25x
Shares Out
58.4M
Financials (TTM)
Revenue
$309.8M
Net Income
$4.3M
EBITDA
$11.8M
Free Cash Flow
$16.9M
Op Cash Flow
$18.3M
EPS Basic
$-0.22
EPS Diluted
$0.06
EPS Forward
$-0.10
Gross Margin
68.2%
Op Margin
-0.1%
Net Margin
1.4%
Balance Sheet
Total Assets
$305.4M
Total Liab.
$75.7M
Total Equity
$229.7M
Cash
$222.0M
LT Debt
$0
Book Value/Sh
$3.93
Debt/Equity
0.00x
Current Ratio
3.60
Quick Ratio
3.54
Returns & Growth
ROE
-5.6%
ROA
-4.2%
ROIC
-5.2%
Rev Growth YoY
+53.2%
EPS Growth YoY
+74.1%
Price Returns
2W
-7.8%
1M
-15.0%
3M
+19.1%
6M
+67.7%
12M
+0.4%
Technicals
52W High
$26.91
52W Low
$10.28
50d MA
$19.93
200d MA
$17.04
RSI (14)
21.50
ATR (14)
$1.06
Beta
1.33
Avg Volume
1.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$22.40
High
$32.00
Low
$15.00
Median
$22.00
Data updated apr 26, 2026 5:22pm
· Source: financialmodelingprep.com